Cargando…

Lower placental 25-hydroxyvitamin D(3) (25(OH)D(3)) and higher placental CYP27B1 and 25(OH)D(3) ratio in preterm birth

Neonatal mortality rates in Indonesia are still at an alarming rate, with preterm birth as one of the causes. Nutritional deficiencies such as low level of vitamin D is suspected to be the risk factors of preterm birth but still a little knowledge about it. Vitamin D metabolism includes 25-hydroxyvi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irwinda, Rima, Andardi, Biancha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681105/ https://www.ncbi.nlm.nih.gov/pubmed/33244402 http://dx.doi.org/10.1017/jns.2020.42

Ejemplares similares

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

25(OH)D status: Effect of D(3) supplement
por: Lukaszuk, J. M., et al.
Publicado: (2017)

Association of Dietary Vitamin D Intake, Serum 25(OH)D(3), 25(OH)D(2) with Cognitive Performance in the Elderly
por: Wang, RuTong, et al.
Publicado: (2021)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Validation and Determination of 25(OH) Vitamin D and 3-Epi25(OH)D3 in Breastmilk and Maternal- and Infant Plasma during Breastfeeding
por: Gjerde, Jennifer, et al.
Publicado: (2020)

Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK
por: Jones, K. S., et al.
Publicado: (2014)

Relationship between serum 25 hydroxyvitamin D (25(OH)D) levels and mental health in shift female nurses
por: Tang, Hsin-Ya, et al.
Publicado: (2022)

Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China
por: Gong, Jinhua, et al.
Publicado: (2022)

25(OH)D(2) Half-Life Is Shorter Than 25(OH)D(3) Half-Life and Is Influenced by DBP Concentration and Genotype
por: Jones, K. S., et al.
Publicado: (2014)

Placental uptake and metabolism of 25(OH)vitamin D determine its activity within the fetoplacental unit
por: Ashley, Brogan, et al.
Publicado: (2022)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

Quantitation of serum 25(OH)D2 and 25(OH)D3 concentrations by liquid chromatography tandem mass spectrometry in patients with diabetes mellitus
por: Lin, Yi-Ching, et al.
Publicado: (2018)

Assessment of Vitamin D Status in Slovenian Premenopausal and Postmenopausal Women, Using Total, Free, and Bioavailable 25-Hydroxyvitamin D (25(OH)D)
por: Vičič, Vid, et al.
Publicado: (2022)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Bioavailable 25(OH)D but Not Total 25(OH)D Is an Independent Determinant for Bone Mineral Density in Chinese Postmenopausal Women
por: Li, Chenguang, et al.
Publicado: (2016)

Serum 25(OH)D, PTH and Correlates of Suboptimal 25(OH)D Levels in Persons with Chronic Spinal Cord Injury
por: Hummel, Kayla, et al.
Publicado: (2012)

Simultaneous determination of vitamin D metabolites 25(OH)D(3) and 1α,25(OH)(2)D(3) in human plasma using liquid chromatography tandem mass spectrometry
por: Xu, Shan, et al.
Publicado: (2022)

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation
por: Kavadichanda, Chengappa, et al.
Publicado: (2023)

Sunlight exposed body surface area is associated with serum 25-hydroxyvitamin D (25(OH)D) level in pregnant Minangkabau women, Indonesia
por: Ilmiawati, Cimi, et al.
Publicado: (2020)

Without 1α-hydroxylation, the gene expression profile of 25(OH)D(3) treatment overlaps deeply with that of 1,25(OH)(2)D(3) in prostate cancer cells
por: Susa, Takao, et al.
Publicado: (2018)

Metabolic Advantage of 25(OH)D(3) versus 1,25(OH)(2)D(3) Supplementation in Infantile Nephropathic Cystinosis-Associated Adipose Tissue Browning and Muscle Wasting
por: Zhou, Ping, et al.
Publicado: (2022)

Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
por: Sollid, Stina T, et al.
Publicado: (2016)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Efficacy of two vitamin D immunoassays to detect 25-OH vitamin D2 and D3
por: Garnett, Emily, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Vitamin D3 Is Transformed into 1,25(OH)(2)D(3) by Triggering CYP3A11(CYP3A4) Activity and Hydrolyzing Midazolam
por: Zhu, Hanfei, et al.
Publicado: (2019)

Lifetime serum concentration of 25-hydroxyvitamin D 25(OH) is associated with hand grip strengths: insight from a Mendelian randomisation
por: Mazidi, Mohsen, et al.
Publicado: (2022)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

Serum 25-hydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) concentrations in adult dogs are more substantially increased by oral supplementation of 25-hydroxyvitamin D(3) than by vitamin D(3)
por: Young, Lauren R., et al.
Publicado: (2017)

Association of serum 25(OH) vitamin D(3) concentration with severity of multiple sclerosis
por: Harandi, Ali Amini, et al.
Publicado: (2012)

Occurrence of Vitamin 25(OH)D(3) Insufficiency in Young Women with Metabolic Syndrome
por: Rogal, Karolina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_narss0iruqg61882n0b25jhdba